Terms: = Colorectal cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Prognosis
5 results:
1. VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer.
Kim JY; Kim EK; Lee WM; Hong YO; Lee H
APMIS; 2020 Oct; 128(10):543-551. PubMed ID: 32794608
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic factors and patterns of recurrence after emergency management for obstructing colon cancer: multivariate analysis from a series of 2120 patients.
Manceau G; Voron T; Mege D; Bridoux V; Lakkis Z; Venara A; Beyer-Berjot L; Abdalla S; Sielezneff I; Lefèvre JH; Karoui M;
Langenbecks Arch Surg; 2019 Sep; 404(6):717-729. PubMed ID: 31602503
[TBL] [Abstract] [Full Text] [Related]
3. Evidence-based quality standards improve prognosis in colon cancer care.
Trautmann F; Reißfelder C; Pecqueux M; Weitz J; Schmitt J
Eur J Surg Oncol; 2018 Sep; 44(9):1324-1330. PubMed ID: 29885983
[TBL] [Abstract] [Full Text] [Related]
4. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
[TBL] [Abstract] [Full Text] [Related]
5. Reduced survival of rectal cancer patients with increased tumor epidermal growth factor receptor levels.
Kopp R; Rothbauer E; Mueller E; Schildberg FW; Jauch KW; Pfeiffer A
Dis Colon Rectum; 2003 Oct; 46(10):1391-9. PubMed ID: 14530681
[TBL] [Abstract] [Full Text] [Related]
